Publications by authors named "Elliot Epner"

Claim this Profile
A
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
Jeffrey J Pu, Kristin N Berger, Chunlei Zheng, Nhan Do, David F Claxton, Elliot M Epner

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
Francis R LeBlanc, Zainul S Hasanali, August Stuart, Sara Shimko, Kamal Sharma, Elliot M Epner

Oncotarget· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mantle cell lymphoma management trends and novel agents: where are we going?
Jeffrey J Pu, Malvi Savani, Nick Huang, Elliot M Epner

Ther Adv Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.
Stephen E Spurgeon, Kamal Sharma, David F Claxton, Christopher Ehmann, Jeffrey Pu, Elliot M Epner

Br J Haematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mantle cell lymphoma and its management: where are we now?
Abdullah Ladha, Jianzhi Zhao, Elliot M Epner, Jeffrey J Pu

Exp Hematol Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
Elliot M Epner, Bikramajit Singh Saroya, Zainul S Hasanali, Thomas P Loughran

Exp Hematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia.
Zainul S Hasanali, Bikramajit Singh Saroya, August Stuart, Sara Shimko, Juanita Evans, Elliot M Epner

Sci Transl Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytes.
Zainul S Hasanali, Elliot M Epner, David J Feith, Thomas P Loughran, Clare E Sample

Mol Cancer Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current approaches to epigenetic therapy for the treatment of mantle cell lymphoma.
Vikas Ghai, Kamal Sharma, Kamal K S Abbi, Sara Shimko, Elliot M Epner

Adv Exp Med Biol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.
Monika Joshi, Hassan Sheikh, Kamal Abbi, Sarah Long, Kamal Sharma, Elliot Epner

Ther Adv Hematol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flipping the cyclin D1 switch in mantle cell lymphoma.
Zainul Hasanali, Kamal Sharma, Elliot Epner

Best Pract Res Clin Haematol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma.
Stephen E Spurgeon, Talia Pindyck, Craig Okada, Yiyi Chen, Zunqiu Chen, Elliot M Epner

Leuk Lymphoma· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients.
Cedar J Fowler, Jennifer Dunlap, Darcy Troyer, Peter Stenzel, Elliot Epner

Adv Hematol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma.
Giampaolo Talamo, Umar Farooq, Maurizio Zangari, Jason Liao, Nathan G Dolloff, Elliot Epner

Clin Lymphoma Myeloma Leuk· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine: not just another purine analogue?
Stephen Spurgeon, Margaret Yu, John D Phillips, Elliot M Epner

Expert Opin Investig Drugs· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma.
Hui Liu, Jing Huang, Jin Wang, Shuguang Jiang, Alexis S Bailey, Elliot Epner

J Exp Med· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Ginna G Laport, Brenda M Sandmaier, Barry E Storer, Bart L Scott, Monic J Stuart, Elliot Epner

Biol Blood Marrow Transplant· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Christoph Kahl, Barry E Storer, Brenda M Sandmaier, Marco Mielcarek, Michael B Maris, Elliot Epner

Blood· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epigenetics of mantle cell lymphoma.
Margaret Yu, Elliot Epner

Curr Treat Options Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.
Richard I Fisher, Steven H Bernstein, Brad S Kahl, Benjamin Djulbegovic, Michael J Robertson, Elliot Epner

J Clin Oncol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sox6 directly silences epsilon globin expression in definitive erythropoiesis.
Zanhua Yi, Orit Cohen-Barak, Nobuko Hagiwara, Paul D Kingsley, Deborah A Fuchs, Elliot M Epner

PLoS Genet· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted deletion of the chicken beta-globin regulatory elements reveals a cooperative gene silencing activity.
Jin Wang, Hui Liu, Chi Mei Lin, Mirit I Aladjem, Elliot M Epner

J Biol Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin D1 activation in B-cell malignancy: association with changes in histone acetylation, DNA methylation, and RNA polymerase II binding to both promoter and distal sequences.
Hui Liu, Jin Wang, Elliot M Epner

Blood· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication initiation patterns in the beta-globin loci of totipotent and differentiated murine cells: evidence for multiple initiation regions.
Mirit I Aladjem, Luo Wei Rodewald, Chii Mai Lin, Sarah Bowman, Daniel M Cimbora, Elliot M Epner

Mol Cell Biol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis